The parents of a terminally ill 20-month-old boy in Liverpool are fighting a legal battle to take him for treatment at the Vatican’s Bambino Gesù hospital in Rome. In a case reminiscent of Charlie Gard’s, doctors believe further treatment for young Alfie Evans would be inappropriate, but his parents have taken Alder Hey Children’s Hospital to court in a bid to move him. Three consultants from the Bambino Gesù hospital visited Alfie in Liverpool and agreed treatment would be “completely futile” in terms of curing him. However, they still offered to take him to Rome for operations to help him breathe and eat, which would allow him to survive for an “undefined period”. Hospital staff in Liverpool say such treatment would be “inappropriate”. Dr Helen Cross said it would prolong his life “unnecessarily” as “his brain is being progressively destroyed and there is no prospect of recovery”. The Anscombe Bioethics Centre said the Alfie Evans case involves “very similar” ethical principles to that of Charlie Gard. “Doctors should not be forced to continue treatment if they believe it offers little or no benefit relative to the burdens it entails, nor should they be forced to refer for specific treatments that they do not believe to be in the best interests of their patient,” the centre said. But the statement added that in the case of infants “parents have prime responsibility for their own child and their rights should not be taken away unless they are acting so unreasonably as to put their child at significant risk”.
12:00 PM
Parents fight to take son to Vatican hospital
Staff writers

Already a subscriber? Sign in
5freearticles every month
Continue reading with a free account. No card needed.
- Five free articles every thirty days, on any device you sign in on
- The Catholic Herald newsletter, every morning
- Subscribe whenever you like for everything: every article and the magazine

subscribe to the catholic herald today
Our best content is exclusively available to our subscribers. Subscribe today and gain instant access to expert analysis, in-depth articles, and thought-provoking insights—anytime, anywhere. Don’t miss out on the conversations that matter most.
Subscribe












